Shortened desensitization leading to a 2-year enzyme replacement therapy with elosulfase alfa.
Ann Allergy Asthma Immunol
; 127(2): 261-262, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-33992778
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Chondroitinsulfatases
/
Desensitization, Immunologic
/
Mucopolysaccharidosis IV
/
Drug Hypersensitivity
/
Enzyme Replacement Therapy
Limits:
Child, preschool
/
Female
/
Humans
Language:
En
Journal:
Ann Allergy Asthma Immunol
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
Turquía
Country of publication:
Estados Unidos